½ day virtual meeting on ATMPs and microbiological related issues – 23rd March (Via Zoom)
Fee: £520 (Member Price £320 – Join Now)
Advance notice: ATMPs & microbiological related issues – Wednesday 23rd March (via Zoom)
Presentations & speakers at a glance:
- Introduction to advanced therapies – Jon Halling – Quality Director, The Cell and Gene Therapy Catapult & Stephen Ward – Chief Manufacturing Officer, The Cell and Gene Therapy Catapult
- Regulations associated with ATMP’s and microbiology – Drew Hope – Consultant QP, ExMoor Pharma Concepts Ltd
- Microbiological considerations for cell and gene therapies – Seb Hodgkin – Senior Director, Quality Assurance, Quell Therapeutics & Pharmig Committee Member
- Rapid microbiological testing of cell and gene therapies – John Duguid – Senior Director R&D, Vericel Corporation (USA) – TBC
Please click here to view the full current draft agenda and booking form
